Cardiovascular Pharmacotherapy

频道
@Cardiovascular_Pharmacotherapy · 未分类 · — · 英语

To Share Updates in Cardiovascular Pharmacotherapy. Admin: @AHTalasaz

广告 B
最近同步 1 天前
收录于 2026-10-19
订阅数 4,869 7 日 +30 · 30 日 —
30 天平均曝光 1,328 近 24h 0
互动率(ERR) 0.0% 7 天发帖 0
广告投放评级 B Ads Index 58

订阅数趋势

10-19 06:38 → 10-28 01:58 · 区间变化 +30

最低 4,839 最高 4,869 2 个采样点

近 30 天曝光

每日帖子浏览总量

暂无曝光数据

每日指标任务运行后生成。

互动与广告

近 30 天帖子聚合

平均反应
0
平均评论
0
平均转发
13.2
广告帖子(30 天)
0
广告占比
0.0%
被提及(30 天)
0

榜单位置

各窗口最近一次榜单

全部榜单 →

暂未进入榜单

频道进入榜单池并满足数据条件后会显示名次。

最近帖子

按发布时间倒序,最多展示 8 条

在 Telegram 查看 →

In Persian

2026-10-19 02:27 👁 715 👍 0 💬 0 ↗ 2

📚 ESC 2026 coverage:Does catheter-directed thrombolysis (CDT) improve clinical outcomes compared with anticoagulation alone in patients with intermediate-high-risk pulmonary embolism? By Dr. Sadeghipour, fellowship of interventional cardiology. 🔗 https://B2n.i…

2026-10-19 02:27 👁 670 👍 0 💬 0 ↗ 4

Catheter-Directed Thrombolysis in Intermediate-High–Risk Pulmonary Embolism (PRAGUE-26)

2026-10-19 02:27 👁 759 👍 0 💬 0 ↗ 8

Cardiovascular Complications of Chronic Liver Disease Circulation State-of-the-Art Review

2026-10-14 02:43 👁 1,136 👍 0 💬 0 ↗ 17

Multidisciplinary Approach to Antiplatelet Management in Coronary Syndromes: A Scientific Statement From the American Heart Association

2026-10-14 02:36 👁 1,058 👍 0 💬 0 ↗ 16

Anticancer Drugs and Cancer-Associated Thrombosis Circulation State-of-the-Art Review

2026-10-06 02:56 👁 1,862 👍 0 💬 0 ↗ 30

In Persian

2026-10-04 20:42 👁 1,565 👍 0 💬 0 ↗ 1

📚 ESC 2026 coverage: Can targeting IL-6 with pacibekitug reduce residual inflammatory risk in patients with CKD and high cardiovascular risk? by Dr. Mohammadi, clinical pharmacist. 🔗 https://B2n.ir/xs4448

2026-10-04 20:42 👁 1,381 👍 0 💬 0 ↗ 1

相似频道

基于 Telegram 官方相似频道推荐

暂无相似频道

等待相似频道抓取任务运行。